Pharmacokinetics of Mycophenolic Acid in Kidney Transplant Patients Receiving Sirolimus Versus Cyclosporine (original) (raw)
Pharmacokinetics and pharmacodynamics of mycophenolate sodium (EC-MPS) co-administered with cyclosporine in the early-phase post-kidney transplantation
Catherine M T Sherwin
Clinical Transplantation, 2012
View PDFchevron_right
Correlation of mycophenolic acid pharmacokinetic parameters with side effects in Chinese kidney transplant recipients treated with mycophenolate mofetil
Raf Schepers
Transplantation Proceedings, 2004
View PDFchevron_right
The pharmacokinetics of mycophenolate mofetil in renal transplant recipients receiving standard-dose or low-dose cyclosporine, low-dose tacrolimus or low-dose sirolimus: the Symphony pharmacokinetic substudy
Domingo Hernández
Nephrology Dialysis Transplantation, 2009
View PDFchevron_right
Increased mycophenolic acid exposure in stable kidney transplant recipients on tacrolimus as compared with those on sirolimus: implications for pharmacokinetics
Lutz Renders
Clinical pharmacology and therapeutics, 2009
View PDFchevron_right
Pharmacokinetic Basis for the Efficient and Safe Use of Low-Dose Mycophenolate Mofetil in Combination with Tacrolimus in Kidney Transplantation
Pierre Wallemacq
2000
View PDFchevron_right
Pharmacokinetics, safety, and efficacy of mycophenolate mofetil in combination with sirolimus or ciclosporin in renal transplant patients
Larry Melton
British Journal of Clinical Pharmacology, 2007
View PDFchevron_right
Pharmacokinetics of mycophenolate mofetil are influenced by concomitant immunosuppression
Guido Filler
Pediatric Nephrology, 2000
View PDFchevron_right
Limited Sampling Models and Bayesian Estimation for Mycophenolic Acid Area under the Curve Prediction in Stable Renal Transplant Patients Co-Medicated with Ciclosporin or Sirolimus
Jean Cumps
Clinical …, 2009
View PDFchevron_right
Evalutation of mycophenolic acid systemic exposure by limited sampling strategy in kidney transplant recipients receiving enteric-coated mycophenolate sodium (EC-MPS) and cyclosporine
Giovanni Tarantino, Giuliano Polichetti, Domenico Capone
Nephrology Dialysis Transplantation, 2011
View PDFchevron_right
Evaluation of Limited Sampling Strategies for Mycophenolic Acid After Mycophenolate Mofetil Intake in Adult Kidney Transplant Recipients
Christine Staatz
2010
View PDFchevron_right
Genetic and nongenetic determinants of between-patient variability in the pharmacokinetics of mycophenolic acid
Dennis Hesselink
Clinical Pharmacology & Therapeutics, 2005
View PDFchevron_right
The need of mycophenolic acid monitoring in long-term renal transplants
Paschoalina Romano
Clinical Transplantation, 2005
View PDFchevron_right
Limited sampling strategies for sirolimus after pediatric renal transplantation
Ajay Sharma
Pediatric Transplantation, 2009
View PDFchevron_right
Tacrolimus pharmacokinetic drug interactions: effect of prednisone, mycophenolic acid or sirolimus
Claudia Felipe
Fundamental & Clinical Pharmacology, 2009
View PDFchevron_right
Time-dependent clearance of mycophenolic acid in renal transplant recipients
Teun Van Gelder
British Journal of Clinical Pharmacology, 2007
View PDFchevron_right
Mycophenolate Mofetil Pharmacokinetic Monitoring in Pediatric Kidney Transplant Recipients
Luca Strologo
Transplantation Proceedings, 2005
View PDFchevron_right
Mycophenolic acid clinical pharmacokinetics influenced by a cyclosporine C2 based immunosuppressive regimen in renal allograft recipients
Anders Hartmann
Transplant International, 2006
View PDFchevron_right
Mycophenolic acid plasma concentrations in kidney allograft recipients with or without cyclosporin: a cross-sectional study
Willem Weimar
Nephrology Dialysis Transplantation, 1999
View PDFchevron_right
Therapeutic Monitoring of Mycophenolate Mofetil in Organ Transplant Recipients
Pierre Wallemacq
Clinical Pharmacokinetics, 2002
View PDFchevron_right
Therapeutic Drug Monitoring of Sirolimus: Effect of Concomitant Immunosuppressive Therapy and Optimization of Drug Dosing
Fabiola Carrara
American Journal of Transplantation, 2004
View PDFchevron_right
Pharmacokinetics and tolerance of mycophenolate mofetil in renal transplant children
A. Maisin, Evelyne Jacqz-aigrain
2000
View PDFchevron_right
Comparison of mycophenolic acid pharmacokinetic parameters in kidney transplant patients within the first 3 months post-transplant
M. Durlik
Journal of Clinical Pharmacy and Therapeutics, 2006
View PDFchevron_right
Co-administration of sirolimus alters tacrolimus pharmacokinetics in a dose-dependent manner in adult renal transplant recipients
Burcin Ekser
Pharmacological Research, 2006
View PDFchevron_right
Limited Sampling Strategy of Mycophenolic Acid in Adult Kidney Transplant Recipients: Influence of the Post-Transplant Period and the Pharmacokinetic Profile
Nadia Ben Fredj
The Journal of Clinical Pharmacology, 2013
View PDFchevron_right
Pharmacokinetics of Mycophenolic Acid after Mycophenolate Mofetil Administration in Liver Transplant Patients Treated with Tacrolimus
Vijay Warty
The Journal of Clinical Pharmacology, 2001
View PDFchevron_right
Pharmacokinetics and Pharmacodynamics of Intensified versus Standard Dosing of Mycophenolate Sodium in Renal Transplant Patients
Petra Glander
Clinical Journal of The American Society of Nephrology, 2010
View PDFchevron_right
Higher exposure to mycophenolic acid with sirolimus than with cyclosporine cotreatment
Yvon Lebranchu
Clinical Pharmacology & Therapeutics, 2005
View PDFchevron_right
Mycophenolate Mofetil Pharmacokinetic Monitoring in Pediatric Kidney Transplant Recipients Under Cyclosporine Based Therapy
Bruno Gianoglio
Transplantation Journal, 2004
View PDFchevron_right
Proton Pump Inhibitor Co-medication Reduces Mycophenolate Acid Drug Exposure in Heart Transplant Recipients
Marcus-André Deutsch
2009
View PDFchevron_right
Abbreviated mycophenolic acid AUC from CO, C1, C2, and C4 is preferable in children after renal transplantation on mycophenolate mofetil and tacrolimus therapy
Guido Filler
Transplant International, 2004
View PDFchevron_right
Unexpected augmentation of mycophenolic acid pharmacokinetics in renal transplant patients receiving tacrolimus and mycophenolate mofetil in combination therapy, and analogous in vitro findings
David Roth
Transplant Immunology, 1997
View PDFchevron_right